For the year ending 2025-12-31, ATXI made $1,404K in revenue. -$2,909K in net income. Net profit margin of -207.19%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Other revenue | 1,404 | |||
| Research and development | 1,037 | |||
| General and administrative | 3,653 | |||
| Gain on sale of baergic | 203 | |||
| Total operating expenses | 4,487 | |||
| Loss from operations | -3,083 | |||
| Interest income | 121 | |||
| Loss on common stock warrant liabilities | 0 | |||
| Change in fair value of warrant liability | -15 | |||
| Net loss | -2,947 | |||
| Net loss attributable to non-controlling interest | -38 | |||
| Net loss attributable to common stockholders | -2,909 | |||
| Basic EPS | -0.93 | |||
| Basic Average Shares | 3,131,131 | |||
AVENUE THERAPEUTICS, INC. (ATXI)
AVENUE THERAPEUTICS, INC. (ATXI)